3Barlogie B,Smith L,Alexanian R.Effective treatment of advanced multiple myeloma refractory to alkylating agents[J].N Engl J Med,1984,310(21):1353-1355 被引量:1
4Singhal S,Mehta J,Deslkan R,et al,Antitumor activity of thalidomide in refractorymultiple myeloma.N Engl J Med,1999,341(18):1565-1571 被引量:1
5Rajkumar SV,GetzMA,LacyMQ,et al.Thalidomide as initial theropy for early stage myeloma[J].Leukemia,2003,17(4):775-779 被引量:1
6Rajkumar SV,Rosiol L,Hussein M,et al.Multicenter,randomized,double-blind,placebo controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma[J].J Clin Oncol,2008,26(13):2171-2177 被引量:1
7Deng L,DingW,Granstein RD.Thalidomide inhibits tumor necrosis factor-αproduction and antigen presentation by Langerhans cells[J].J Invest Dermatol,2003,121(5):1060-1065 被引量:1
8Weber D,Rankin K,Gavino M,et al.Thalidomide alone or with dexamethasone for previous untreated multiple myeloma[J].J Clin Oncol,2003,21(1):16-19 被引量:1
9Zangari M,Anaissie E,Barlogie B,et al.Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy[J].Blood,2001,98(5):1614-1615 被引量:1
10Osman K,Comenzo R,Rajkumar S V.Deep vein thrombosis and thalidomide therapy for multiple myeloma[J].N Engl J Med,2001,344(25):1951-1952 被引量:1